#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4051302	B	Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay	Homo sapiens	32		cell-based format	Scientific Literature
2.	ALA4051303	B	Agonist activity at human GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay relative to control	Homo sapiens	32		cell-based format	Scientific Literature
3.	ALA4051304	F	Agonist activity at mouse GPR40 expressed in HEK293 cells assessed as increase in intracellular calcium level after 5 mins by FLUO-4-AM dye-based FLIPR assay	Mus musculus	30		cell-based format	Scientific Literature
4.	ALA4051305	F	Agonist activity at mouse GPR40 expressed in HEK293 cells assessed as increase in intracellular calcium level after 5 mins by FLUO-4-AM dye-based FLIPR assay relative to control	Mus musculus	30		cell-based format	Scientific Literature
5.	ALA4051306	P	Octanol-buffer partition coefficient, log D of the compound at pH 7.4 after 30 mins by LC-UV based shake-flask method		19		small-molecule physicochemical format	Scientific Literature
6.	ALA4051315	A	Protein binding in mouse plasma assessed as unbound fraction after 24 hrs by equilibrium dialysis	Mus musculus	5		cell-free format	Scientific Literature
7.	ALA4051317	A	Clearance in mouse at 1 mg/kg, iv after 24 hrs	Mus musculus	1		organism-based format	Scientific Literature
8.	ALA4051319	A	Volume of distribution at steady state in mouse at 1 mg/kg, iv after 24 hrs	Mus musculus	1		organism-based format	Scientific Literature
9.	ALA4051320	A	Cmax in mouse at 5 mg/kg administered through oral gavage after 24 hrs	Mus musculus	5		organism-based format	Scientific Literature
10.	ALA4051321	A	Oral bioavailability in mouse at 5 mg/kg after 24 hrs	Mus musculus	5		organism-based format	Scientific Literature
11.	ALA4051322	A	Ratio of drug level in mouse brain to blood at 5 mg/kg administered through oral gavage after 2 hrs	Mus musculus	5		organism-based format	Scientific Literature
12.	ALA4051323	A	Ratio of unbound drug level in mouse brain to blood at 5 mg/kg administered through oral gavage after 2 hrs	Mus musculus	4		organism-based format	Scientific Literature
13.	ALA4051324	A	Apparent permeability across apical to basolateral side in human Caco2 cells	Homo sapiens	4		cell-based format	Scientific Literature
14.	ALA4051325	A	Efflux ratio of permeability in MDCK2-MDR1 cells at 10 uM	Canis lupus familiaris	4		cell-based format	Scientific Literature
15.	ALA4051326	F	Antidiabetic activity in C57BL/6J mouse assessed as reduction in glucose excursion at 100 mg/kg administered through oral gavage 30 mins prior to glucose challenge measured after 90 mins by OGTT relative to control	Mus musculus	2		organism-based format	Scientific Literature
16.	ALA4051327	F	Antidiabetic activity in wild-type mouse assessed as reduction in glucose excursion at 100 mg/kg administered through oral gavage 30 mins prior to glucose challenge measured after 90 mins by OGTT relative to control	Mus musculus	2		organism-based format	Scientific Literature
17.	ALA4051328	F	Antidiabetic activity in GPR120 knockout mouse assessed as reduction in glucose excursion at 100 mg/kg administered through oral gavage 30 mins prior to glucose challenge measured after 90 mins by OGTT	Mus musculus	2		organism-based format	Scientific Literature
18.	ALA4051329	B	Inhibition of Adenosine A2A receptor (unknown origin)	Homo sapiens	1		single protein format	Scientific Literature
19.	ALA4051331	B	Agonist activity at mouse GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay	Mus musculus	7		cell-based format	Scientific Literature
20.	ALA4051332	B	Agonist activity at mouse GPR120 expressed in CHO-FlpIn cells after 15 mins by DMR assay relative to control	Mus musculus	7		cell-based format	Scientific Literature